Search Results - "Amary, Fernanda M"
-
1
Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone
Published in Nature genetics (01-12-2013)“…Adrienne Flanagan and colleagues identify distinct driver mutations in H3F3A and H3F3B in chondroblastoma and giant cell tumor of bone. The mutations occur in…”
Get full text
Journal Article -
2
Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2
Published in Nature communications (18-07-2013)“…Isocitrate dehydrogenase ( IDH ) genes 1 and 2 are frequently mutated in acute myeloid leukaemia (AML), low-grade glioma, cholangiocarcinoma (CC) and…”
Get full text
Journal Article -
3
Undifferentiated Sarcomas Develop through Distinct Evolutionary Pathways
Published in Cancer cell (18-03-2019)“…Undifferentiated sarcomas (USARCs) of adults are diverse, rare, and aggressive soft tissue cancers. Recent sequencing efforts have confirmed that USARCs…”
Get full text
Journal Article -
4
The H3F3 K36M mutant antibody is a sensitive and specific marker for the diagnosis of chondroblastoma
Published in Histopathology (01-07-2016)“…Aims We recently reported that 95% of chondroblastomas harbour a p.K36M mutation in either H3F3A (chromosome 1) or H3F3B (chromosome 17), with the majority…”
Get full text
Journal Article -
5
Detection of USP6 gene rearrangement in nodular fasciitis: an important diagnostic tool
Published in Virchows Archiv : an international journal of pathology (01-07-2013)Get full text
Journal Article -
6
Next-generation sequencing is highly sensitive for the detection of beta-catenin mutations in desmoid-type fibromatoses
Published in Virchows Archiv : an international journal of pathology (01-08-2015)“…Desmoid-type fibromatoses are locally aggressive and frequently recurrent tumours, and an accurate diagnosis is essential for patient management. The majority…”
Get full text
Journal Article -
7
Fibroblastic growth factor receptor 1 amplification in osteosarcoma is associated with poor response to neo‐adjuvant chemotherapy
Published in Cancer medicine (Malden, MA) (01-08-2014)“…Osteosarcoma, the most common primary bone sarcoma, is a genetically complex disease with no widely accepted biomarker to allow stratification of patients for…”
Get full text
Journal Article -
8
Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma: characterization of five cases
Published in Skeletal radiology (01-07-2013)“…Objective To describe the imaging and histopathology of pseudomyogenic hemangioendothelioma. Materials and methods Five cases of pseudomyogenic…”
Get full text
Journal Article -
9
IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours
Published in The Journal of pathology (01-07-2011)“…Somatic mutations in isocitrate dehydrogenase 1 (IDH1) and IDH2 occur in gliomas and acute myeloid leukaemia (AML). Since patients with multiple enchondromas…”
Get full text
Journal Article -
10
Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma
Published in Nature communications (23-06-2017)“…Osteosarcoma is a primary malignancy of bone that affects children and adults. Here, we present the largest sequencing study of osteosarcoma to date,…”
Get full text
Journal Article -
11
Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2
Published in Nature genetics (01-12-2011)“…Adrienne Flanagan and colleagues report the identification of somatic mosaic mutations in the IDH1 and IDH2 genes in tumors from individuals with Ollier…”
Get full text
Journal Article -
12
The driver landscape of sporadic chordoma
Published in Nature communications (12-10-2017)“…Chordoma is a malignant, often incurable bone tumour showing notochordal differentiation. Here, we defined the somatic driver landscape of 104 cases of…”
Get full text
Journal Article -
13
A common single-nucleotide variant in T is strongly associated with chordoma
Published in Nature genetics (01-11-2012)“…Adrienne Flanagan and colleagues identify a common variant in the T gene associated with strong risk of chordoma, a rare malignant bone tumor. The risk variant…”
Get full text
Journal Article -
14
GNAS mutations are not detected in parosteal and low-grade central osteosarcomas
Published in Modern pathology (01-10-2015)“…Parosteal osteosarcoma, low-grade central osteosarcoma, and fibrous dysplasia share similar histological features that may pose a diagnostic challenge. The…”
Get full text
Journal Article -
15
Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study
Published in The Journal of pathology (01-02-2011)“…A variety of analyses, including fluorescence in situ hybridization (FISH), quantitative PCR (qPCR) and array CGH (aCGH), have been performed on a series of…”
Get full text
Journal Article -
16
Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast‐rich mimics
Published in The journal of pathology. Clinical research (01-04-2015)“…Driver mutations in the two histone 3.3 (H3.3) genes, H3F3A and H3F3B, were recently identified by whole genome sequencing in 95% of chondroblastoma (CB) and…”
Get full text
Journal Article -
17
Isocitrate dehydrogenase 1 mutations (IDH1) and p16/CDKN2A copy number change in conventional chondrosarcomas
Published in Virchows Archiv : an international journal of pathology (01-02-2015)“…To determine whether IDH1 mutations are present in primary and relapsed (local and distal) conventional central chondrosarcomas; and secondly, to assess if…”
Get full text
Journal Article -
18
IDH1 mutations are not found in cartilaginous tumours other than central and periosteal chondrosarcomas and enchondromas
Published in Histopathology (01-01-2012)Get full text
Journal Article -
19
Assessment of MUC4 expression in primary bone tumours
Published in Histopathology (01-07-2013)Get full text
Journal Article -
20
P63 does not regulate brachyury expression in human chordomas and osteosarcomas
Published in Histopathology (01-11-2011)Get full text
Journal Article